Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: Improving Quality of Care for Patients With Recurrent Ovarian Cancer
An update on a clinical trial investigating improvements in quality of care for patients with recurrent ovarian cancer.
-
FDA approval · 2016-06-16FDA Approved: LEVOLEUCOVORIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s levoleucovorin as an Original Application generic; levoleucovorin is used in cancer regimens w…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating adding Bevacizumab (Avastin) to carboplatin and paclitaxel in ovarian cancer; results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Cancer Prevention in Women With a BRCA Mutation [Phase 1]
This is a Phase 1 clinical trial update addressing cancer prevention in women carrying BRCA1 or BRCA2 gene mutations.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab for ovarian cancer has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]
Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results w…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the PARP inhibitor rucaparib in BRCA1/BRCA2 mutation carriers with locally advanced or metastatic…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors [Phase 1, Phase 2]
This clinical trial update reports on the results of combining chemotherapy with peripheral stem cell transplantation in patients with germ …
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: FR in Stored Plasma
Clinical trial update noting the completion of a study investigating FR in stored plasma for ovarian cancer. The snippet provides limited de…
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
This completed clinical trial update focuses on studying biomarkers in samples from younger patients with malignant germ cell tumor progress…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies [Phase 2]
Phase 2 clinical trial evaluating sequential angiogenic blockade for recurrent Mullerian malignancies, completed with results posted in 2016…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
This clinical trial update from National Taiwan University Hospital investigates the expression of altered glycosyltransferases, mucins, and…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
Clinical trial update on follow-up of gynecological cancer patients, focusing on their needs and expectations, covering endometrial, ovarian…
-
CLINICAL_TRIALS withdrawal · 2016-05-02Clinical Trial Update: Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations [Phase 3]
Phase 3 trial of olaparib maintenance versus placebo in platinum-sensitive relapsed ovarian cancer with sBRCAm or HRR gene mutations has bee…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating letrozole (Femara) versus placebo for ovarian, fallopian tube, or primary peritoneal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer [Phase 2]
Phase II study of ipilimumab monotherapy in recurrent platinum-sensitive ovarian cancer completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update on combination chemotherapy for stage III/IV ovarian epithelial cancer or primary peritoneal cancer; study completed wi…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Risk Education and Assessment for Cancer Heredity [NA]
A completed University of Utah trial evaluating risk education and assessment for hereditary cancer predisposition, including breast and ova…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study [Phase 2]
Clinical trial update indicates the Phase 2 feasibility study of minimally invasive interval debulking surgery for stage IV ovarian carcinom…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen-sponsored trial evaluating neutropenia and anemia management in patients with solid tumors receiving myelotoxic chemotherapy has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane [Phase 3]
A Phase 3 trial comparing chemotherapy versus hormonal treatment in platinum-resistant ovarian cancer (including peritoneal and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
A completed clinical trial evaluated early detection of ovarian cancer using GC/FT-ICR mass spectrometry and canine olfaction. The study foc…
-
CLINICAL_TRIALS research · 2016-03-25Clinical Trial Update: Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study
This retrospective study evaluates predictive biomarkers for IGF1R-targeted therapy in ovarian cancer to inform patient selection and guide …
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]
A Phase 2 single-arm study evaluating carboplatin/gemcitabine with BSI-201 in platinum-sensitive recurrent ovarian cancer has completed enro…